20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Cure3 Announced – 80 leading artists and fashion designers unite for a selling exhibition in aid of The Cure Parkinson’s Trust
11 June 2020 The Cure Parkinson’s Trust, in association with Bonhams and Artwise, is delighted to announce Cure3 2020, the 3rd edition of the acclaimed selling exhibition devised to raise awareness and funds for curative Parkinson’s research. Featuring original artworks by more than 80 international…
Webinar – Neurotrophic Factors and Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. The panel of experts include: Chair – Prof Patrik Brundin, Dr. Howard Federoff – Professor of Neurology and Neuroscience, University of California; Prof. Mart Saarma – Research Director, University of Helsinki and…
PDCORE
Assessing the progression of Parkinson’s is a very difficult task, but accurately doing so is critical to our ability to evaluate the disease modifying potential of new therapies. The clinical measures currently used in clinical trials have been developed using large longitudinal studies that assessed individuals over long periods of time. […]
MAMS the word
The way that clinical trials are conducted doesn’t make much sense. They take too long and a lot of resources to set up, they take a long time to be conducted, and we have to wait until they are finished before we get the results. And then on top of that […]
MAMS the word
The way that clinical trials are conducted doesn’t make much sense. They take too long and a lot of resources to set up, they take a long time to be conducted, and we have to wait until they are finished before we get the results. And then on top of that […]